Publication: Growth Arrest-Specific 6 and Cardiometabolic Risk Factors in Patients with Psoriasis
Loading...
Program
relationships.isAuthorOf
Author
Cagman, Zeynep
Gerin, Fethullah
ÖZGEN, ZÜLEYHA
Durmus, Erdal
Seckin, Dilek
Ahmad, Sarfraz
Uras, Fikriye
Agirbasli, Mehmet
Advisor
Language
Type
Publisher
Journal Title
Journal ISSN
Volume Title
Abstract
ObjectivesAn increased risk for cardiovascular disease with psoriasis has been reported. Growth Arrest-Specific 6 (GAS6) amplifies pro-inflammatory endothelial cell activation via TAM receptors. However, it also inhibits inflammation by multiple mechanisms including phagocytosis. The objective of this study was to investigate whether plasma GAS6 levels are associated with conventional cardiometabolic (CM) risk factors in patients with psoriasis.
Description
Source
Keywords
Keywords
Citation
SÜNBÜL M., Cagman Z., Gerin F., ÖZGEN Z., Durmus E., Seckin D., Ahmad S., Uras F., Agirbasli M., -Growth Arrest-Specific 6 and Cardiometabolic Risk Factors in Patients with Psoriasis-, CARDIOVASCULAR THERAPEUTICS, cilt.33, ss.56-61, 2015